1-((4,6-dimethyl-5-pyrimidinyl)carbonyl)-4-(4-(2-methoxy-4-(trifluoromethyl)phenyl)ethyl-3-methyl-1-piperazinyl)-4-methylpiperidine,
Sch 417690,
Sch-417690,
Sch417690,
vicriviroc,
Vicriviroc maleate,
599179-03-0,
Vicriviroc (maleate),
UNII-EP3QG127N9,
Vicriviroc maleate [USAN],
EP3QG127N9,
Sch 417690,
Vicriviroc maleate (USAN),
vicriviroc maleate,
MK-4176,
vicriviroc maleate; SCH-D,
SCH-D (maleate),
AC1O52UW,
SCH-417690 (maleate),
CHEMBL2107384,
AKOS015924409,
CS-1019,
AN-15533,
BC203210,
HY-17377,
D06297,
W-3966,
44609-EP2270008A1,
44609-EP2272516A2,
44609-EP2281819A1,
44609-EP2292617A1,
44609-EP2292619A1,
44609-EP2305659A1,
44609-EP2311818A1,
J-690330,
(4,6-dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-piperazin-1-yl]-4-methyl-1-piperidyl]methanone; maleic acid,
(4,6-Dimethylpyrimidin-5-yl){4-[(3S)-4-{(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl}-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}methanone (2Z)-but-2-enedioate,
(Z)-but-2-enedioic acid; (4,6-dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone,
1-((4,6-Dimethylpyrimidin-5-yl)carbonyl)-4-((3S)-4-((1R)-2-methoxy-1-(4-(trifluoromethyl)phenyl)ethyl)-3-methylpiperazin-1-yl)-4-methylpiperidine (2Z)-but-2-enedioate,
5-({4-[(3S)-4-{(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl}-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine (2Z)-but-2-enedioate,
Piperidine, 1-((4,6-dimethyl-5-pyrididinyl)carbonyl)-4-((3S)-4-((1R)-2-methoxy-1-(4-(trifluoromethyl)phenyl)ethyl)-3-methyl-1-piperazinyl)-4-methyl-, (2Z)-2-butenedioate (2:1),
Cevipabulin,
Vicriviroc,
SCH-D,
AC-820,
CID6451165,
SCH-417690,
1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]-4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methylpiperidine malate,